Focused Alpha’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BIO
Focused Alpha's BIO Position: Q3 2026 in Review
Focused Alpha held its Bio-Rad Laboratories Class A (BIO) position steady in Q3 2026 at 4,205 shares worth $1.59M. The position accounts for 0.4% of the portfolio, ranked #48.
Focused Alpha first reported a position in BIO in Q4 2025 and has held it in 4 quarters since. 327 funds tracked by Wall St. Rank hold BIO as of Q3 2026.
- Focused Alpha held 4,205 shares of Bio-Rad Laboratories Class A worth $1.59M as of Q3 2026.
- Focused Alpha left its Bio-Rad Laboratories Class A share count unchanged in Q3 2026.
- Bio-Rad Laboratories Class A made up 0.4% of Focused Alpha's portfolio in Q3 2026, its #48 holding.
- Focused Alpha first reported a position in Bio-Rad Laboratories Class A in Q4 2025 and has held it in 4 quarters since.
- 327 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.
Based on Focused Alpha's 13F filing for Q3 2026, filed 20 Oct 2026.